PACS PACS Group, Inc.

QT81

NYSE·Healthcare·Medical - Care Facilities·USA

Latest market price

46.02

+0.44+0.97%

Overview Short InterestFilings

PACSQT81PACS Group, Inc.·NYSE

Overview Short InterestFilings

46.02+0.97%

Earnings

Up 1.0% — Reported earnings — EPS beat by 17%, revenue beat by 1%.

High confidence

Loading chart...

Signal & projected range

Insider selling clusterHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

CHE-0.25%$540.84 HIMS+1.51%$25.61 UHS-0.89%$179.04 CON+0.04%$40.34 LFST+1.75%$13.49 ENSG+0.77%$180.44 OPCH+0.02%$31.70 DVA-2.13%$181.79

Snapshot

Index	—	P/E	27.29	EPS (ttm)	1.67	Insider Own	—	Shs Outstand	158.34M	Perf Week	-6.52%

Market Cap	7.22B	Forward P/E	16.87	EPS next Y	2.70	Insider Trans	-1.64%	Shs Float	49.25M	Perf Month	6.37%

Enterprise Value	10.15B	PEG	2.73	EPS next Q	0.58			Short Float	8.80%	Perf Quarter	1.72%

Income	269.00M	P/S	1.30	EPS this Y	40.36%			Short Ratio	5.46	Perf Half Y	40.16%

Sales	5.55B	P/B	6.47	EPS next Y	10.69%	ROA	4.76%	Short Interest	4.33M	Perf YTD	18.73%

Book/sh	7.04	P/C	44.00	EPS next 5Y	10.00%	ROE	27.15%	52W High	50.38 -8.65%	Perf Year	272.39%

Cash/sh	1.04	P/FCF	15.79	EPS past 3/5Y	6.85% —	ROIC	6.06%	52W Low	10.31 346.36%	Perf 3Y	—

Dividend Est.	—	EV/EBITDA	21.14	Sales past 3/5Y	29.74% —	Gross Margin	19.68%	Volatility	3.94% 3.71%	Perf 5Y	—

Dividend TTM	—	EV/Sales	1.83	EPS Y/Y TTM	103.66%	Oper. Margin	7.39%	ATR (14)	1.86	Perf 10Y	—

Dividend Ex-Date	—	Quick Ratio	0.91	Sales Y/Y TTM	15.17%	Profit Margin	4.85%	RSI (14)	48.56	Recom	2.00

Dividend Gr. 3/5Y	—	Current Ratio	0.91	EPS Q/Q	13.51%	SMA20	-1.51%	Beta	0.27	Target Price	56.67

Payout	0.00%	Debt/Eq	2.78	Sales Q/Q	9.09%	SMA50	3.10%	Rel Volume	1.11	Prev Close	45.58

Employees	47,455	LT Debt/Eq	2.77	Earnings	Nov 03	SMA200	14.68%	Avg Volume	785.22K	Price	46.02

IPO Date	Apr 11, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.43% 1.00%	Net Debt/EBITDA	6.11	Volume	874,671	Change	0.97%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Sep-02-26	Reiterated	Truist Financial	Buy	$52 → $62
Aug-06-26	Reiterated	UBS	Buy	$57 → $60
Jul-08-26	Reiterated	UBS	Buy	$42 → $57
May-18-26	Reiterated	Truist Securities	Buy	$40 → $52
May-13-26	Reiterated	Oppenheimer	Outperform	$40 → $48
Feb-27-26	Reiterated	RBC Capital	Outperform	$47 → $52
Dec-19-25	Reiterated	RBC Capital	Outperform	$33 → $47
Dec-18-25	Resumed	UBS	Buy	$42
Dec-12-25	Reiterated	Truist Financial	Buy	$32 → $40
Nov-20-25	Reiterated	RBC Capital	Outperform	$30 → $33

Latest News· Times ET

Nov-02-26

Nov-02-2606:02AM

PACS Group (NYSE:PACS) CAO Sells $118,294.56 in Stockdefenseworld.net

06:02AM

PACS Group (NYSE:PACS) CEO Sells $95,295.20 in Stockdefenseworld.net

Oct-30-26

Oct-30-2603:30AM

What Might The October Job Report Look Like?SeekingAlpha

Oct-29-26

Oct-29-2607:15AM

NYSE: PACS ALERT: Investors in PACS Group, Inc. (NYSE: PACS) Shares Should Contact the Shareholders Foundation Regarding Lawsuitbusinesswire.com

Oct-27-26

Oct-27-2604:22PM

PACS Group Schedules Third Quarter 2026 Earnings Release and Conference Callbusinesswire.com

04:13AM

PACS Group (NYSE:PACS) CEO Jason Hulse Murray Sells 68,917 Shares of Stockdefenseworld.net

04:13AM

PACS Group (NYSE:PACS) CEO Jason Hulse Murray Sells 13,696 Shares of Stockdefenseworld.net

Oct-23-26

Oct-23-2603:49AM

Cantor Fitzgerald Investment Advisors L.P. Makes New Investment in PACS Group, Inc. $PACSdefenseworld.net

Oct-21-26

Oct-21-2604:50PM

Medpace (MEDP) Q3 Earnings and Revenues Beat EstimatesYahoo

Oct-19-26

Oct-19-2605:42AM

Insider Selling: PACS Group (NYSE:PACS) CEO Sells $10,440.00 in Stockdefenseworld.net

04:52AM

PACS Group (NYSE:PACS) CEO Sells $402,875.82 in Stockdefenseworld.net

Oct-18-26

Oct-18-2604:09AM

PACS Group (NYSE:PACS) Stock: Insider Jason Hulse Murray Sells 110,035 Sharesdefenseworld.net

Oct-16-26

Oct-16-2608:55AM

PACS Group, Inc. (PACS) Surges 6.2%: Is This an Indication of Further Gains?zacks.com

03:17AM

Lease Expansion Could Reshape The Case For PACS Group (PACS) StockYahoo

Oct-14-26

Oct-14-2603:54AM

PACS Group: Strong Growth Opportunities But The Valuation Is JustifiedSeekingAlpha

Company

PACS Group, Inc. operates as a holding company, primarily focused on delivering post-acute healthcare services. This encompasses operating various facilities, providing skilled professionals, and offering essential ancillary support. The company further specializes in providing a spectrum of senior living options, encompassing dedicated senior care, assisted living, and independent living residences in select communities. Founded in 2013 by Jason Murray and Mark Hancock, its corporate headquarters are located in Farmington, Utah.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021
Total Revenue	5,551	5,289	4,090	3,111	—	—
Cost of Goods Sold Incl. D&A	4,458	4,130	3,297	2,664	—	—
Gross Profit	1,092	1,159	793	447	—	—
Selling, General and Administrative Excl. Other	442	415	344	214	—	—
Research and Development	0	0	0	0	—	—
Other Operating Expense	240	435	326	25	—	—
Operating Income	410	310	123	208	—	—
Interest Expense	30	28	44	50	—	—
Unusual Expense	—	—	—	—	—	—
Non-Operating Income (Expense)	3	3	23	-1	—	—
Net Income Before Taxes	383	284	102	157	—	—
Income Taxes	113	93	46	44	—	—
Consolidated Net Income	269	192	56	113	—	—
Net Income From Continuing Operations	269	192	55	113	—	—
Net Income	269	192	56	113	—	—
EPS (Recurring)	1.70	1.23	0.38	0.75	—	—
EPS (Basic, Before Extraordinaries)	1.70	1.23	0.38	0.75	—	—
EPS (Diluted)	1.67	1.22	0.38	0.75	—	—
EBITDA	480	366	187	233	—	—
Other After Tax Adjustments	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—
Price To Earnings Ratio	27.56	31.47	34.50	—	—	—
Price To Sales Ratio	1.31	1.13	0.47	—	—	—
Gross Margin	19.67	21.91	19.39	14.37	—	—
Operating Margin	7.39	5.86	3.01	6.69	—	—
Net Margin	4.85	3.63	1.37	3.63	—	—
Shares Outstanding	158	156	147	150	—	—
Market Capitalization	7,271	5,989	1,927	—	—	—
Operating Lease Expense	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lewis Michelle Renee	Chief Accounting Officer	Oct 29 '26	Sale	50.04	2,364	118,283	343,510	Oct 30
Murray Jason Hulse	Co-Founder, CEO & Chairman	Oct 29 '26	Sale	50.05	1,904	95,289	54,179,397	Oct 30
Hancock Mark	Director, 10% Owner	Oct 29 '26	Sale	50.02	4,280	214,101	53,505,580	Oct 30
Lewis Michelle Renee	Chief Accounting Officer	Oct 28 '26	Sale	50.12	9,464	474,365	345,874	Oct 30
Murray Jason Hulse	Co-Founder, CEO & Chairman	Oct 28 '26	Sale	50.10	6,899	345,624	54,181,301	Oct 30
Hancock Mark	Director, 10% Owner	Oct 28 '26	Sale	50.10	9,024	452,120	53,509,860	Oct 30
Murray Jason Hulse	Co-Founder, CEO & Chairman	Oct 23 '26	Sale	48.60	68,917	3,349,176	54,188,200	Oct 26
Murray Jason Hulse	Co-Founder, CEO & Chairman	Oct 22 '26	Sale	47.55	13,696	651,211	54,257,117	Oct 26
Murray Jason Hulse	Co-Founder, CEO & Chairman	Oct 21 '26	Sale	47.62	6,610	314,755	54,270,813	Oct 21
Murray Jason Hulse	Co-Founder, CEO & Chairman	Oct 20 '26	Sale	47.65	37,477	1,785,820	54,277,423	Oct 21
Murray Jason Hulse	Co-Founder, CEO & Chairman	Oct 19 '26	Sale	47.57	1,620	77,060	54,314,900	Oct 21
Murray Jason Hulse	Co-Founder, CEO & Chairman	Oct 16 '26	Sale	47.61	8,462	402,876	54,316,520	Oct 16
Murray Jason Hulse	Co-Founder, CEO & Chairman	Oct 15 '26	Sale	47.27	110,035	5,201,352	54,324,982	Oct 16
Murray Jason Hulse	Co-Founder, CEO & Chairman	Oct 14 '26	Sale	45.00	232	10,440	54,435,017	Oct 16
Jergensen Joshua	President & COO	Oct 14 '26	Sale	44.50	40,000	1,780,004	2,456,320	Oct 16

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.